Skip to main content
Premium Trial:

Request an Annual Quote

Astex Joins Cancer Drug Discovery Collaboration

NEW YORK, March 22 (GenomeWeb News) - Astex Technology has formed an exclusive collaboration with The Wellcome Trust, the Institute of Cancer Research, and Cancer Research Technology to discover novel drugs against the cancer target BRAF, the partners said today.


The Wellcome Trust, the Instituteof Cancer Research, and Cancer Research Technology began a partnership focusing on BRAF last year, and have now been joined by Astex, which will contribute its fragment-based drug discovery expertise.


"There is excellent synergy between the collaborating parties," Ted Bianco, director of technology transfer at The Wellcome Trust, said in a statement. "Astex's structure-based approach to drug discovery is highly complementary to the cancer therapeutic resources of the other parties."


The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.